CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary
CryoTherapeutics has raised €29M across 3 funding rounds from 12 investors, most recently a Series B round in Apr 2024. Based in Awans, Belgium; founded 2009; active in Healthtech. Data as of 6 Aug 2026.
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2024-04-02 | Series B | €10M | GED Ventures Portugal,Innomedical,KfW,Noshaq,NRW.Bank,Peppermint Venture Partners+1 more | View deal → |
| 2022-02-17 | Other | €12M | Creathor Ventures,Getz,High-Tech Gruenderfonds,KfW,Noshaq Group,NRW.Bank+2 more | View deal → |
| 2019-07-01 | Series B | €7.0M | Meusinvest | View deal → |
